From CNBC: 2025-04-25 14:07:00

Novo Nordisk wins legal victory restricting compounding pharmacies from selling unapproved versions of Ozempic and Wegovy. Patients turned to cheaper copycats during supply shortages. Judge rejects bid from compounding group, FDA can take action against pharmacies making compounded drugs. Novo Nordisk continues legal actions to protect against illegitimate drugs. Eli Lilly also cracking down on compounding pharmacies for their weight loss and diabetes drugs.



Read more at CNBC: Novo Nordisk legal win bars many compounded Wegovy, Ozempic drugs